Quay Pharma is now part of sgs logoopens in a new window

Quay News

SGS Quay Pharma’s Facility Brings Formulation and Manufacturing Expertise to North America

The need for comprehensive, technically advanced, and integrated services from contract service providers is needed now more than ever.

October 17 2022 - Quay News

Read More

SGS’s Quay Pharma Collaborates to Develop New Oral Medicine for Inflammatory Bowel Disease

SGS’s Quay Pharma has partnered with Intract Pharma, CPI and Pharmidex to successfully…

July 18 2022 - Quay News

Read More

New Hampshire Pharmaceutical Development and Clinical Manufacturing Facility Nears Completion

We will soon open our Hudson, NH, pharmaceutical development and clinical manufacturing facility.

July 12 2022 - Quay News

Read More

Acquisition Will Further Strengthen Quay Offering

Quay Pharma has been acquired by SGS, the Swiss-based world leading (TIC) Testing, Inspection and Certification company.

December 10 2021 - Quay News

Read More

Now Recruiting in the US

Now Recruiting in the US. We have significantly extended our presence in the United States with the securing of a 55,000 sq ft facility for pharmaceutical development…

March 22 2021 - Quay News

Read More